Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05890365 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Study description revisedv6
  2. Notable Primary completion date: Aug 2025 to Jun 2026
    • Study completion date: Aug 2025 to Dec 2026
    v5
  3. Notable Primary and study completion dates: Dec 2024 to Aug 2025
    • Eligibility criteria shortened, about 8 words
    v4
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 2023 to Dec 14, 2023
    • Study sites: 0 to 1
    v3
  5. Minor Secondary endpoints: details revised at 6 of 6 entriesv2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators recently demonstrated a increase in liver fat in early middle-aged LBW compared to normal birth weight (NBW) men, and 20% of the LBW - but none of the normal birth weight (NBW) - men had previously unknown non-alcoholic fatty liver disease (NAFLD). Here the investigators will further examine the Increased risk of non-alcoholic fatty liver disease in low birth weight individuals by performing a validation study.
Trial Details
NCT Number NCT05890365
Lead Sponsor Steno Diabetes Center Copenhagen
Collaborators: Aarhus University Hospital, Lund University
Conditions
(from sponsor)
Non-Alcoholic Fatty Liver Disease, Low Birth Weight
Related terms Fatty Liver, Metabolic Diseases, Non-alcoholic Fatty Liver Disease
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov